HURA (TuHURA Biosciences) Shares Outstanding (EOP): 63.58 Mil (As of Mar. 2026)


HURA TuHURA Biosciences Inc HURA
12 GF Score
Price $2.23
! 1 Warning Sign
View Full Analysis

What is TuHURA Biosciences Shares Outstanding (EOP)?

TuHURA Biosciences HURA -16.60% 12 Shares Outstanding (EOP) is 63.58 Mil as of Mar. 2026. GuruFocus rates HURA with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. TuHURA Biosciences's shares outstanding for the quarter that ended in Mar. 2026 was 63.58 Mil.

TuHURA Biosciences's quarterly shares outstanding increased from Dec. 2025 (59.34 Mil) to Mar. 2026 (63.58 Mil). It means TuHURA Biosciences issued new shares from Dec. 2025 to Mar. 2026 .

TuHURA Biosciences's annual shares outstanding increased from Dec. 2024 (42.32 Mil) to Dec. 2025 (59.34 Mil). It means TuHURA Biosciences issued new shares from Dec. 2024 to Dec. 2025 .


TuHURA Biosciences  (NAS:HURA) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


TuHURA Biosciences Shares Outstanding (EOP) Related Terms


TuHURA Biosciences Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for TuHURA Biosciences's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TuHURA Biosciences Shares Outstanding (EOP) Chart

TuHURA Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
12.18 12.18 11.89 42.32 59.34

TuHURA Biosciences Quarterly Data
Dec21 Mar22 Dec22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.68 49.91 51.26 59.34 63.58

HURA vs AGEN, CRBP, SPRB: Shares Outstanding (EOP) Comparison

For the Biotechnology subindustry, TuHURA Biosciences's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TuHURA Biosciences Shares Outstanding (EOP) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TuHURA Biosciences's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where TuHURA Biosciences's Shares Outstanding (EOP) falls into.


HURA
12GF Score
TuHURA Biosciences Inc HURA
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TuHURA Biosciences Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 63.58 Mil mean?
TuHURA Biosciences (HURA) has a Shares Outstanding (EOP) of 63.58 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on TuHURA Biosciences and its competitors.
Is TuHURA Biosciences' Shares Outstanding (EOP) too high?
TuHURA Biosciences' current Shares Outstanding (EOP) is 63.58 Mil. Overall, TuHURA Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TuHURA Biosciences' Shares Outstanding (EOP) compare to AGEN and CRBP?
TuHURA Biosciences' Shares Outstanding (EOP) of 63.58 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Biotechnology company?
A good Shares Outstanding (EOP) depends on the Biotechnology industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on TuHURA Biosciences and its competitors. TuHURA Biosciences's current Shares Outstanding (EOP) is 63.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TuHURA Biosciences stock overvalued right now?
TuHURA Biosciences (HURA) has a current Shares Outstanding (EOP) of 63.58 Mil. The current Shares Outstanding (EOP) is 63.58 Mil. TuHURA Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For TuHURA Biosciences (HURA), the current Shares Outstanding (EOP) is 63.58 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TuHURA Biosciences Business Description

Other Exchanges PL3:Germany
Address 10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
12GF Score

Get the complete analysis for HURA

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.23
Price